Days
Hours
Minutes
Seconds

Improving lives with constant updates & research and promising a better & healthier future!

W

Welcome Message

It is my pleasure to welcome you to the 1st Middle East Cardiovascular Pharmacotherapy Forum to be held on 14th October 2023 at Jumeirah Creekside hotel, Dubai.

In this emerging era of increased heart disease, particularly in the Middle East region, we take this opportunity to discuss the latest advancement in cardiovascular pharmacotherapy and to have our forum as a “Call for Action” for implementing guideline directed medical therapy in our region.

This inaugural version of the forum will aim to bring together prominent individuals in the field ‎both in the region and internationally and will be inclusive of all cardiovascular ‎pharmacotherapy practice settings. ‎

We look forward to welcoming you in Dubai. With your important contribution we aim to have ‎MECVPT forum as the primary scientific gathering of cardiovascular pharmacotherapy ‎specialists in the region and to become an awaited yearly event.

Dr. Bassam Atallah

 Pharm.D., M.S., BCPS-AQ Cardiology, FHFSA
Chairman, MECVPT 2023
Clinical Associate Professor
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Heart and Vascular Institute Pharmacotherapy Specialist
Cleveland Clinic Abu Dhabi
United Arab Emirates

O

Our Faculty

*Faculty is arranged Alphabetically

Ahmad El Ouweini
Critical Care Clinical Pharmacist and Clinical Lecturer
Gulf Medical University
United Arab Emirates
Ahmed Aljedai
Founding President
Saudi Society of Clinical Pharmacy (SSCP)
Assistant Deputy Minister for Therapeutic Affairs
Ministry of Health, Riyadh
Saudi Arabia

Ahmed Aldemerdash​
Chairman, Pharmacy Scientific Council Saudi Commission for Health Specialties (SCFHS) ​
Saudi Arabia​

Amnah Mukhtar
Head Medication
Safety/Clinical Pharmacy Support Services
King Faisal Specialist Hospital and Research Center, Jeddah
Saudi Arabia
Antoine Cherfan
Senior Director
Pharmacotherapy Services
Cleveland Clinic Abu Dhabi
United Arab Emirates
Bassam Atallah​
Senior Pharmacotherapy Specialist​ Department of Pharmacy Services ​ Cleveland Clinic Abu Dhabi
United Arab Emirates
Bassam R. Ali​
Professor of Genomic Medicine
College of Medicine and Health Sciences
United Arab Emirates University
United Arab Emirates
Craig James Beavers​​
Vice President, Operations Executive/Clinical Leader for Cardiovascular, Surgical Services, Pharmacy, Oncology/Radiology, Facilities, Environmental Services, Business Development, Food and Nutrition Services Baptist Health Paducah
United States​
Emad El Kholy​​
Cardiology/Critical care
Pharmacist​
King Abdullah Medical City​
Saudi Arabia​​
Emadeldin Hosney Eldaly​​
Clinical Pharmacist / Cardiology and internal medicine​
Sheikh Khalifa medical city (SKMC)​
United Arab Emirates
Fakhr Z. AlAyoubi
President, Saudi Cardio Clinical Pharmacy Group at the Saudi Heart Association
Saudi Heart Society
Saudi Arabia
Hisham Badreldin Associate Professor
Consultant Cardiovascular Pharmacotherapy Specialist
Department of Pharmacy
Practice, College of Pharmacy
King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS)
King Abdullah International Medical Research Center (KAIMRC)
King Abdulaziz Medical City (KAMC)
Ministry of National Guard Health Affairs (MNGHA) Riyadh
Saudi Arabia
Jamila Alaryani​​​
PGY1 Pharmacy Resident
Cleveland Clinic Abu Dhabi
United Arab Emirates
Kazuhiko Kido​​​
Clinical Associate Professor​ Clinical Pharmacy West Virginia University (WVU) School of Pharmacy​
United States​
Mohamad Shara​​​
Visiting Associate Professor of Clinical Pharmacy
University of Sharjah, College of pharmacy
United Arab Emirates
Nibal Chamoun​​​ Clinical Associate Professor and Assistant Dean of Experiential Education and Residency Program
Lebanese American University (LAU) School of Pharmacy (SOP)
Lebanon
Rahmeh Qandil​​​
Clinical Tutor
University of Sharjah, College of Pharmacy
United Arab Emirates
Salahdein Mohammed AbuRuz​​​
Director of PharmD and PhD programs, Professor of Clinical Pharmacy and Pharmacotherapy/ Department of Pharmacology and Therapeutics, United Arab Emirate University
United Arab Emirates​
Saad Sultan
Executive Director of Pharmacy Services
Cleveland Clinic Abu Dhabi
United Arab Emirates
Said Nabil​
International Relations Committee
Heart Failure Society of America (HFSA)
Researcher Cleveland Clinic Abu Dhabi
United Arab Emirates
Salma Alzaabi​​​
Clinical staff Pharmacist
Cleveland Clinic Abu Dhabi
United Arab Emirates
Sana Hasan​​​​
Associate Professor of Clinical Pharmacy & Coordinator of the MSc in Clinical Pharmacy Program
Ajman University College of Pharmacy and Health Sciences
United Arab Emirates
Seeba Zachariah​​​​
Clinical Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, Gulf Medical University
United Arab Emirates​
Ziad Sadik​
Senior Pharmacotherapy Specialist: Cardiology and Internal Medicine Cleveland Clinic Abu Dhabi​
United Arab Emirates

A

Agenda

Session 1
Chairperson : ABC

Dr. Mohamed Salah

Topic 1

Dr. Mohamed Salah

Topic 2

Dr. Mohamed Salah

Topic 3

Topic 4

Discussion

Prayer & Lunch

Session 2
Chairperson : Prof. ABC

Dr. Mohamed Salah

Topic 1

Dr. Mohamed Salah

Topic 2

Discussion

Coffee Break

Session 3
Chairperson : Dr. ABC

Dr. Mohamed Salah

Topic 1

Dr. Mohamed Salah

Topic 2

Dr. Mohamed Salah

Topic 3

Discussion

Coming Soon

Click on the session name for more details about the session
cURL Error #:Could not resolve host: events.mme-conferences.com

O

Our Location

Jumeirah Creekside Hotel, Dubai

S

Silver Sponsors

Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 103,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world. Find out more at https://www.novartis.com

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com

A

Associate Sponsors

C

Contact Us